GLOBAL TRUST COMPANY has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan AMERICAN CENTURY HIGH YIELD CORPORATE BOND TRUST
| Measure | Date | Value |
|---|
| 2022 : AMERICAN CENTURY HIGH YIELD CORPORATE BOND TRUST 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-17,708,850 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-17,708,850 |
| Total transfer of assets to this plan | 2022-12-31 | $794,375,423 |
| Total transfer of assets from this plan | 2022-12-31 | $497,646,643 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $102,329 |
| Total income from all sources (including contributions) | 2022-12-31 | $-20,328,827 |
| Total loss/gain on sale of assets | 2022-12-31 | $-11,470,664 |
| Total of all expenses incurred | 2022-12-31 | $461,803 |
| Value of total assets at end of year | 2022-12-31 | $276,040,479 |
| Value of total assets at beginning of year | 2022-12-31 | $0 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $461,803 |
| Total interest from all sources | 2022-12-31 | $8,779,138 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $71,549 |
| Administrative expenses professional fees incurred | 2022-12-31 | $138,248 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-31 | $391,363 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2022-12-31 | $224,645 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $5,197,949 |
| Assets. Loans (other than to participants) at end of year | 2022-12-31 | $978,394 |
| Assets. Loans (other than to participants) at beginning of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $102,329 |
| Administrative expenses (other) incurred | 2022-12-31 | $4,990 |
| Total non interest bearing cash at end of year | 2022-12-31 | $19,169 |
| Total non interest bearing cash at beginning of year | 2022-12-31 | $0 |
| Value of net income/loss | 2022-12-31 | $-20,790,630 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $275,938,150 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $0 |
| Investment advisory and management fees | 2022-12-31 | $318,565 |
| Interest earned on other investments | 2022-12-31 | $8,779,138 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $4,663,460 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $0 |
| Income. Dividends from common stock | 2022-12-31 | $71,549 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $263,916,281 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $649,218 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Aggregate proceeds on sale of assets | 2022-12-31 | $131,249,796 |
| Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $142,720,460 |
Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.
See full terms and conditions
